Milton Packer
Baylor University
H-index: 150
North America-United States
Top articles of Milton Packer
Glucagon-like peptide-1 receptor agonists across the spectrum of heart failure
2024/1
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis
Circulation
2024/4/7
Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart Failure
Journal of the American College of Cardiology
2024/4/6
Milton Packer
H-Index: 81
EFFECTS OF SACUBITRIL/VALSARTAN IN PATIENTS WITH HEART FAILURE ACROSS THE SPECTRUM OF KIDNEY RISK
Journal of the American College of Cardiology
2024/4/2
Brian Claggett
H-Index: 62
Milton Packer
H-Index: 81
SACUBITRIL/VALSARTAN, TREATMENT-RELATED HYPOTENSION, AND LEFT VENTRICULAR EJECTION FRACTION IN THE PARAGON-HF TRIAL
Journal of the American College of Cardiology
2024/4/2
OBESITY AND ADVERSE CARDIAC REMODELING IN HFPEF: THE PARAGON-HF TRIAL
Journal of the American College of Cardiology
2024/4/2
ABDOMINAL OBESITY AND OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE PARAGON-HF TRIAL
Journal of the American College of Cardiology
2024/4/2
Brian Claggett
H-Index: 62
Milton Packer
H-Index: 81
Mechanistic and clinical comparison of the erythropoietic effects of SGLT2 inhibitors and prolyl hydroxylase inhibitors in patients with chronic kidney disease and renal anemia
2024/4/2
Milton Packer
H-Index: 81
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR‐Pooled analysis
Diabetes, Obesity and Metabolism
2024/4/1
Jennifer Green
H-Index: 2
Gerasimos Filippatos
H-Index: 105
João Pedro Ferreira
H-Index: 8
Milton Packer
H-Index: 81
Body mass index and cardiorenal outcomes in the EMPEROR‐Preserved trial: Principal findings and meta‐analysis with the DELIVER trial
European Journal of Heart Failure
2024/4/1
Sacubitril/Valsartan-Related Hypotension in Patients with Heart Failure and Preserved or Mildly Reduced Ejection Fraction
Journal of the American College of Cardiology
2024/3/25
Milton Packer
H-Index: 81
Orly Vardeny
H-Index: 25
Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme
European Journal of Heart Failure
2024/3/4
Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR‐Preserved analysis
European Journal of Heart Failure
2024/3/4
The Ideal Heart Rate for Heart Failure and Ejection Fraction> 40%: Both Myth and Magic?
Journal of Cardiac Failure
2024/3/1
Milton Packer
H-Index: 81
Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR‐Preserved
Nature medicine
2022/12
Independent prognostic importance of blood urea nitrogen to creatinine ratio in heart failure
European journal of heart failure
2024/2
Toru Kondo
H-Index: 11
Milton Packer
H-Index: 81
Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials
European Journal of Heart Failure
2023/12/1
João Pedro Ferreira
H-Index: 8
Naveed Sattar
H-Index: 125
Gerasimos Filippatos
H-Index: 105
Milton Packer
H-Index: 81
Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan
ESC Heart Failure
2024/2
Transcatheter aortic valve replacement in heart failure
2024/1/31
Michael Mack
H-Index: 18
Milton Packer
H-Index: 81
Early changes in estimated glomerular filtration rate post‐initiation of empagliflozin in EMPEROR‐Preserved
European Journal of Heart Failure
2024/1/21
João Pedro Ferreira
H-Index: 8
Gerasimos Filippatos
H-Index: 105
Christoph Wanner
H-Index: 12
Milton Packer
H-Index: 81
